These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8180830)

  • 1. Effects of brain-derived neurotrophic factor and nerve growth factor on remaining neurons in the lesioned nucleus basalis magnocellularis.
    Dekker AJ; Fagan AM; Gage FH; Thal LJ
    Brain Res; 1994 Mar; 639(1):149-55. PubMed ID: 8180830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins.
    Burke MA; Mobley WC; Cho J; Wiegand SJ; Lindsay RM; Mufson EJ; Kordower JH
    Exp Neurol; 1994 Dec; 130(2):178-95. PubMed ID: 7867749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection.
    Morse JK; Wiegand SJ; Anderson K; You Y; Cai N; Carnahan J; Miller J; DiStefano PS; Altar CA; Lindsay RM
    J Neurosci; 1993 Oct; 13(10):4146-56. PubMed ID: 8080477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons.
    Koliatsos VE; Price DL; Gouras GK; Cayouette MH; Burton LE; Winslow JW
    J Comp Neurol; 1994 May; 343(2):247-62. PubMed ID: 8027442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of delayed treatment with nerve growth factor on choline acetyltransferase activity in the cortex of rats with lesions of the nucleus basalis magnocellularis: dose requirements.
    Dekker AJ; Thal LJ
    Brain Res; 1992 Jul; 584(1-2):55-63. PubMed ID: 1515953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term and complete reversal of NGF effects in rats with lesions of the nucleus basalis magnocellularis.
    Winkler J; Power AE; Ramirez GA; Thal LJ
    Brain Res; 1998 Mar; 788(1-2):1-12. PubMed ID: 9554932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesions of the nucleus basalis magnocellularis in the rat: morphological, biochemical and behavioral reparative effect of nerve growth factor and ganglioside GM1.
    Casamenti F; Milan F; Pepeu G
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):461-73. PubMed ID: 2130662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats.
    Garofalo L; Cuello AC
    Exp Neurol; 1994 Feb; 125(2):195-217. PubMed ID: 8313938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellularis.
    Dekker AJ; Winkler J; Ray J; Thal LJ; Gage FH
    Neuroscience; 1994 May; 60(2):299-309. PubMed ID: 8072685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor.
    Williams LR; Inouye G; Cummins V; Pelleymounter MA
    J Pharmacol Exp Ther; 1996 May; 277(2):1140-51. PubMed ID: 8627526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between nerve growth factor and GM1 monosialoganglioside in preventing cortical choline acetyltransferase and high affinity choline uptake decrease after lesion of the nucleus basalis.
    Di Patre PL; Casamenti F; Cenni A; Pepeu G
    Brain Res; 1989 Feb; 480(1-2):219-24. PubMed ID: 2713652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nerve growth factor treatment on rats with lesions of the nucleus basalis magnocellularis produced by ibotenic acid, quisqualic acid, and AMPA.
    Winkler J; Thal LJ
    Exp Neurol; 1995 Dec; 136(2):234-50. PubMed ID: 7498413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricular application of BDNF and NT-3 failed to protect nucleus basalis magnocellularis cholinergic neurones.
    Skup MH; Figueiredo BC; Cuello AC
    Neuroreport; 1994 May; 5(9):1105-9. PubMed ID: 8080966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nerve growth factor and GM1 ganglioside on the recovery of cholinergic neurons after a lesion of the nucleus basalis in aging rats.
    Casamenti F; Scali C; Giovannelli L; Faussone-Pellegrini MS; Pepeu G
    J Neural Transm Park Dis Dement Sect; 1994; 7(3):177-93. PubMed ID: 7710670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microencapsulated nerve growth factor: effects on the forebrain neurons following devascularizing cortical lesions.
    Maysinger D; Jalsenjak I; Cuello AC
    Neurosci Lett; 1992 Jun; 140(1):71-4. PubMed ID: 1407703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nerve growth factor (NGF) in rats with basal forebrain lesions.
    Ogawa S; Nabeshima T; Kameyama T; Hayashi K
    Jpn J Pharmacol; 1993 Feb; 61(2):141-4. PubMed ID: 8459651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of brain-derived neurotrophic factor and ciliary neurotrophic factor on cultured basal forebrain cholinergic neurons from postnatal 2-week-old rats.
    Hashimoto Y; Abiru Y; Nishio C; Hatanaka H
    Brain Res Dev Brain Res; 1999 Jun; 115(1):25-32. PubMed ID: 10366699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor increases cortical choline acetyltransferase-positive fiber staining without affecting cortical cholinergic neurons.
    Dekker AJ; Thal LJ
    Brain Res; 1993 Jan; 601(1-2):329-32. PubMed ID: 8431782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed treatment with nerve growth factor improves acquisition of a spatial task in rats with lesions of the nucleus basalis magnocellularis: evaluation of the involvement of different neurotransmitter systems.
    Dekker AJ; Gage FH; Thal LJ
    Neuroscience; 1992; 48(1):111-9. PubMed ID: 1374860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain.
    Garofalo L; Cuello AC
    J Pharmacol Exp Ther; 1995 Feb; 272(2):527-45. PubMed ID: 7853166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.